Tilray Canada Ltd., eine Tochtergesellschaft von Tilray Inc. (NASDAQ: TLRY), dem globalen Vorreiter in der Herstellung, Forschung und dem...
GlaxoSmithKline PLC (GSK) and U.S. partner Tolerx, Inc. said Friday their experimental drug otelixizumab failed to achieve its target in a...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.